secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGILE THERAPEUTICS INC (—)
CIK:        0001261249
Form:       8-K
Filed at:   2023-04-10T23:59:59+00:00
Accession:  0001558370-23-005697
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Agile Therapeutics announces 1-for-50 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse split effective 4:00 PM ET April 10, 2023; trading begins split-adjusted April 11 under symbol AGRX.
- Shares outstanding reduced from ~46.6M to ~932,101; no fractional shares, cash in lieu.
- Split intended to raise bid price to meet Nasdaq minimum bid price listing requirement.
- CUSIP changes to 00847L308; Broadridge acts as exchange agent for the split.
- Proportional adjustments to exercise prices and share counts of outstanding stock options and warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1261249/000155837023005697/0001558370-23-005697-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1261249/000155837023005697/agrx-20230410x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-005697

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer